SCA
ARCT icon

Snowden Capital Advisors’s Arcturus Therapeutics ARCT Stock Holding History

Snowden Capital Advisors’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-19,660
Closed -$479K – 1217
2024
Q2 		$479K Buy
19,660
+533
+3% +$16.2K 0.01% 775
2024
Q1 		$646K Buy
19,127
+7,502
+65% +$266K 0.02% 648
2023
Q4 		$367K Buy
11,625
+2,248
+24% +$53.4K 0.01% 837
2023
Q3 		$240K Hold
9,377
– – 0.01% 940
2023
Q2 		$269K Hold
9,377
– – 0.01% 998
2023
Q1 		$225K Sell
9,377
-6,489
-41% -$116K 0.01% 1041
2022
Q4 		$269K Hold
15,866
– – 0.01% 959
2022
Q3 		$235K Sell
15,866
-4,480
-22% -$75.2K 0.01% 979
2022
Q2 		$320K Hold
20,346
– – 0.01% 830
2022
Q1 		$548K Buy
20,346
+2,655
+15% +$67.8K 0.02% 606
2021
Q4 		$654K Sell
17,691
-14,324
-45% -$584K 0.03% 405
2021
Q3 		$1.53M Buy
32,015
+106
+0.3% +$4.75K 0.08% 300
2021
Q2 		$1.08M Sell
31,909
-11,362
-26% -$385K 0.05% 355
2021
Q1 		$1.79M Buy
43,271
+13,328
+45% +$794K 0.1% 253
2020
Q4 		$1.3M Buy
29,943
+17,789
+146% +$1.2M 0.09% 267
2020
Q3 		$521K Buy
+12,154
New +$603K 0.04% 376

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Snowden Capital Advisors's ARCT Position: Q3 2024 in Review

Snowden Capital Advisors sold out of Arcturus Therapeutics (ARCT) in Q3 2024, closing a stake of 19,660 shares — an estimated $479K sold.

Snowden Capital Advisors first reported a position in ARCT in Q3 2020 and held it in 16 quarters. The position peaked at $1.79M in Q1 2021. 164 funds tracked by Wall St. Rank hold ARCT as of Q3 2024.

  • Snowden Capital Advisors reported no remaining Arcturus Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 19,660 Arcturus Therapeutics shares in Q3 2024, an estimated $479K.
  • Snowden Capital Advisors first reported a position in Arcturus Therapeutics in Q3 2020 and held it in 16 quarters.
  • Snowden Capital Advisors's Arcturus Therapeutics position peaked at $1.79M in Q1 2021.
  • 164 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2024.

Based on Snowden Capital Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.